eScholarship
metadata only
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
Artemisinin partial resistance may facilitate selection of Plasmodium falciparum resistant to combination therapy partner drugs. We evaluated 99 P. falciparum isolates collected in 2021 from northern Uganda, where resistance-associated PfK13 C469Y and A675V mutations have emerged, and eastern Uganda
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevalence of pfkelch13 Mutations and Clinical Indicators of Artemisinin Partial Resistance in Africa: A Systematic Review and Meta-Analysis of Observational Cohorts#353178
- Convergent evolution of artemisinin and chloroquine resistance in Ethiopian Plasmodium falciparum parasites#274975
- Spatial Surveillance of Plasmodium falciparum Kelch 13 Mutations Reveals Emerging Artemisinin Resistance in Kenya#231422
- Estimating the changing prevalence of molecular markers of artemisinin partial resistance in <i>Plasmodium falciparum</i> malaria in Sub-Saharan Africa#414798
- Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar#1009559
Record · ID 1119880
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive